ZANGOTOZ Trademark

Trademark Overview

On Monday, September 28, 2020, a trademark application was filed for ZANGOTOZ with the United States Patent and Trademark Office. The USPTO has given the ZANGOTOZ trademark a serial number of 90215936. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, October 17, 2023. This trademark is owned by Acorda Therapeutics, Inc.. The ZANGOTOZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations used in the treatment of diseases, disorders or conditions of the nervous system
zangotoz

General Information

Serial Number90215936
Word MarkZANGOTOZ
Filing DateMonday, September 28, 2020
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, October 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 24, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations used in the treatment of diseases, disorders or conditions of the nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, November 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAcorda Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPearl River, NY 10965
Party NameAcorda Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressArdsley, NY 10502

Trademark Events

Event DateEvent Description
Thursday, October 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 17, 2023SOU EXTENSION 4 GRANTED
Tuesday, October 17, 2023SOU EXTENSION 4 FILED
Tuesday, October 17, 2023SOU TEAS EXTENSION RECEIVED
Saturday, April 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 13, 2023SOU EXTENSION 3 GRANTED
Thursday, April 13, 2023SOU EXTENSION 3 FILED
Thursday, April 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 4, 2022SOU EXTENSION 2 GRANTED
Tuesday, October 4, 2022SOU EXTENSION 2 FILED
Tuesday, October 4, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, April 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 4, 2022SOU EXTENSION 1 GRANTED
Monday, April 4, 2022SOU EXTENSION 1 FILED
Monday, April 4, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 2, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 2, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 2, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 2, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 2, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 19, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 24, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 24, 2021PUBLISHED FOR OPPOSITION
Wednesday, August 4, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 21, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 21, 2021ASSIGNED TO LIE
Friday, July 2, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 23, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 23, 2021NON-FINAL ACTION E-MAILED
Tuesday, February 23, 2021NON-FINAL ACTION WRITTEN
Saturday, February 20, 2021ASSIGNED TO EXAMINER
Sunday, November 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 1, 2020NEW APPLICATION ENTERED

Related Keywords

zangotoz conditions nervous system disorders diseases preparations used treatment pharmaceutical